Skip to main content
رجوع
JDHIY logo

JD Health International Inc.

جودة البيانات: 100%
ذروة بيع
JDHIY
OTC Healthcare Medical - Care Facilities
KWD 6.85
KWD 0.00 (0.00%)
القيمة السوقية: 21.93B
مُدرج أيضًا باسم JDHIF OTC
نطاق اليوم
KWD 6.85 KWD 7.00
نطاق 52 أسبوعًا
KWD 3.81 KWD 9.08
حجم التداول
500
متوسط 50 يوم / 200 يوم
KWD 8.82 / KWD 7.85
الإغلاق السابق
KWD 6.85

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (627 نظير)

المقياس السهم وسيط القطاع
P/E 4.2 0.3
P/B 0.4 2.9
ROE % 9.1 3.7
Net Margin % 7.3 3.8
Rev Growth 5Y % 23.5 10.0
D/E 0.0 0.2

السعر المستهدف للمحللين

لا تتوفر تغطية محللين

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2027 KWD 0.000
KWD 0.000 – KWD 0.000
100 B 0
FY2026 KWD 0.000
KWD 0.000 – KWD 0.000
87 B 0

النقاط الرئيسية

Revenue grew 23.53% annually over 5 years — strong growth
Earnings grew 25.64% over the past year
Debt/Equity of 0.01 — conservative balance sheet
Negative free cash flow of 0.0
P/E of 4.19 — trading at a low valuation
ROIC of 4.56% — low return on invested capital

النمو

Revenue Growth (5Y)
23.53%
Revenue (1Y)22.83%
Earnings (1Y)25.64%
FCF Growth (3Y)N/A

الجودة

Return on Equity
9.07%
ROIC4.56%
Net Margin7.32%
Op. Margin5.17%

الأمان

Debt / Equity
0.01
Current Ratio2.72
Interest Coverage342.21

التقييم

P/E Ratio
4.19
P/B Ratio0.36
EV/EBITDA-2.50
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 22.83% Revenue Growth (3Y) 15.52%
Earnings Growth (1Y) 25.64% Earnings Growth (3Y) 56.25%
Revenue Growth (5Y) 23.53% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 71.44B Net Income (TTM) 5.23B
ROE 9.07% ROA 6.41%
Gross Margin 24.78% Operating Margin 5.17%
Net Margin 7.32% Free Cash Flow (TTM) 0.0
ROIC 4.56% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.01 Current Ratio 2.72
Interest Coverage 342.21 Dividend Yield 0.00%
Valuation
P/E Ratio 4.19 P/B Ratio 0.36
P/S Ratio 0.31 PEG Ratio 1.41
EV/EBITDA -2.50 Dividend Yield 0.00%
Market Cap 21.93B Enterprise Value -9.25B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 71.44B 58.16B 53.53B 46.74B 30.68B
Net Income 5.23B 4.16B 2.14B 380.11M -1.07B
EPS (Diluted) 1.61 1.32 0.68 0.12 -0.35
Gross Profit 17.70B 13.31B 11.87B 9.89B 7.20B
Operating Income 3.69B 1.48B 630.85M 803.11M -857.14M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 81.64B 71.27B 64.29B 61.28B 48.00B
Total Liabilities 21.53B 16.03B 14.92B 16.49B 8.15B
Shareholders' Equity 60.11B 55.23B 49.36B 44.78B 39.85B
Total Debt 636.42M 258.39M 214.75M 199.41M 201.27M
Cash & Equivalents 31.81B 22.63B 15.04B 18.72B 17.25B
Current Assets 56.38B 58.46B 47.85B 56.45B 45.71B
Current Liabilities 20.75B 15.52B 14.58B 16.36B 8.01B

درجات الاستراتيجيات

This stock passed the criteria for 4 strategies

Score = fit strength (0–100)
Rank = position among all matches
#682 of 825
25
#216 of 618
45
Custom Full Throttle
#111 of 146
31

النشاط الأخير

دخل Deep Value Investing (Seth Klarman)
Mar 24, 2026
دخل Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
دخل Defensive Investing (Benjamin Graham)
Mar 24, 2026
دخل Full Throttle
Mar 24, 2026